Medinet Co., Ltd. (Japan)

Alternate names: Medinet, Medinet Co., Ltd., 株式会社メディネット

ROR: 003m9jr97

OpenAlex ID: I4405263801

Clinical and immunological evaluation of zoledronate-activated Vγ9γδ T-cell-based immunotherapy for patients with multiple myeloma

2009 · Yu Abe, Masato Muto, et al. · Experimental Hematology · 189

Zoledronate facilitates large-scale ex vivo expansion of functional γδ T cells from cancer patients for use in adoptive immunotherapy*

2008 · M. Kondo, K. Sakuta, et al. · Cytotherapy · 169

Chemotherapy and zoledronate sensitize solid tumour cells to Vγ9Vδ2 T cell cytotoxicity

2007 · Stephen R. Mattarollo, Tony Kenna, et al. · Cancer Immunology Immunotherapy · 166

Adoptive Immunotherapy for Advanced Non-small Cell Lung Cancer Using Zoledronate-expanded γδ T Cells: A Phase I Clinical Study

2011 · Miki Sakamoto, Jun Nakajima, et al. · Journal of Immunotherapy · 155

An Immunogram for the Cancer-Immunity Cycle: Towards Personalized Immunotherapy of Lung Cancer

2017 · Takahiro Karasaki, Kazuhiro Nagayama, et al. · Journal of Thoracic Oncology · 154

Characterization and Mutational Analysis of the RecQ Core of the Bloom Syndrome Protein

2003 · Pavel Janscak, Patrick L Garcia, et al. · Journal of Molecular Biology · 122

A Combination Therapy of Gemcitabine With Immunotherapy for Patients With Inoperable Locally Advanced Pancreatic Cancer

2009 · Yoshiki Hirooka, Akihiro Itoh, et al. · Pancreas · 117

Cytotoxic T Lymphocytes Block Tumor Growth Both by Lytic Activity and IFNγ-Dependent Cell-Cycle Arrest

2014 · Hirokazu Matsushita, Akihiro Hosoi, et al. · Cancer Immunology Research · 110

PDF

Zoledronate-activated Vγ9γδ T cell-based immunotherapy is feasible and restores the impairment of γδ T cells in patients with solid tumors

2010 · Atsutaka Noguchi, Toru Kaneko, et al. · Cytotherapy · 100

Expansion of Human Peripheral Blood γδ T Cells using Zoledronate

2011 · Makoto Kondo, Takamichi Izumi, et al. · Journal of Visualized Experiments · 96

PDF

Ex vivo characterization of γδ T-cell repertoire in patients after adoptive transfer of Vγ9Vδ2 T cells expressing the interleukin-2 receptor β-chain and the common γ-chain

2013 · Takamichi Izumi, Makoto Kondo, et al. · Cytotherapy · 89

A combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancer

2009 · Yoshiki Hirooka, Akihiro Itoh, et al. · Suizo · 88

Increased diversity with reduced “diversity evenness” of tumor infiltrating T-cells for the successful cancer immunotherapy

2018 · Akihiro Hosoi, Kazuyoshi Takeda, et al. · Scientific Reports · 73

PDF

Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole‐exome sequencing

2016 · Takahiro Karasaki, Kazuhiro Nagayama, et al. · Cancer Science · 70

PDF

Activation and suppression of renin–angiotensin system in human dendritic cells

2002 · Natalia Lapteva, Kazuki Ide, et al. · Biochemical and Biophysical Research Communications · 70

Stimulation of human butyrophilin 3 molecules results in negative regulation of cellular immunity

2010 · Hiromichi Yamashiro, Shinji Yoshizaki, et al. · Journal of Leukocyte Biology · 67

Children's ideas of animals' internal structures

2007 · P.avol Prokop, M.atej Prokop, et al. · Journal of Biological Education · 67

The peripheral blood Vα24+NKT cell numbers decrease in patients with haematopoietic malignancy

2004 · Ken-ichirou Yoneda, Takeshi Morii, et al. · Leukemia Research · 67

Myeloid molecular characteristics of human γδ T cells support their acquisition of tumor antigen-presenting capacity

2015 · Masato Muto, Muhammad Baghdadi, et al. · Cancer Immunology Immunotherapy · 50

NK cell and IFN signatures are positive prognostic biomarkers for resectable pancreatic cancer

2017 · Mayumi Hoshikawa, Taku Aoki, et al. · Biochemical and Biophysical Research Communications · 48

Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosuppressive mechanismviarecruitment of myeloid-derived suppressor cells: Recruitment of monocytic MDSC in the tumor by CTLs

2013 · Akihiro Hosoi, Hirokazu Matsushita, et al. · International Journal of Cancer · 48

Human peripheral blood Vα24+ Vβ11+ NKT cells expand following administration of α‐galactosylceramide‐pulsed dendritic cells

2002 · M. Okai, M. Nieda, et al. · Vox Sanguinis · 48

Illegitimate recombination mediated by double-strand break and end-joining in

2004 · H IKEDA, K SHIRAISHI, et al. · Advances in Biophysics · 45

Impaired and imbalanced cellular immunological status assessed in advanced cancer patients and restoration of the T cell immune status by adoptive T-cell immunotherapy

2013 · Atsutaka Noguchi, Toru Kaneko, et al. · International Immunopharmacology · 39

PDF

Dendritic cell vaccine induces antigen-specific CD8+ T cells that are metabolically distinct from those of peptide vaccine and is well-combined with PD-1 checkpoint blockade

2017 · Koji Nagaoka, Akihiro Hosoi, et al. · OncoImmunology · 38

PDF

Works count: 105

Citation count: 8,381